User profiles for Y. Ishikawa

Yuichi Ishikawa

- Verified email at jfcr.or.jp - Cited by 39361

Yutaka Ishikawa

- Verified email at is.su-tokyo.ac.jp - Cited by 8213

[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …

…, T Mitsudomi, RM Huber, Y Ishikawa… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

[HTML][HTML] The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification

…, DB Flieder, K Geisinger, FR Hirsch, Y Ishikawa… - Journal of thoracic …, 2015 - Elsevier
The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura,
Thymus and Heart has just been published with numerous important changes from the 2004 …

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society …

…, K Geisinger, Y Yatabe, Y Ishikawa… - … of Pathology and …, 2013 - meridian.allenpress.com
The new International Association for the Study of Lung Cancer/American Thoracic Society/European
Respiratory Society lung adenocarcinoma classification provides, for the first time, …

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

…, S Ohno, Y Ishikawa, H Aburatani, T Niki, Y Sohara… - Nature, 2007 - nature.com
Improvement in the clinical outcome of lung cancer is likely to be achieved by identification
of the molecular events that underlie its pathogenesis. Here we show that a small inversion …

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

…, M Matsuzaki, Y Matsuzawa, Y Saito, Y Ishikawa… - The lancet, 2007 - thelancet.com
Background Epidemiological and clinical evidence suggests that an increased intake of long-chain
n-3 fatty acids protects against mortality from coronary artery disease. We aimed to …

[HTML][HTML] EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors

…, T Hamada, H Haruta, Y Ishikawa… - … England Journal of …, 2010 - Mass Medical Soc
<p id="p001">The EML4 (echinoderm microtubule-associated protein-like 4)–ALK (anaplastic
lymphoma kinase) fusion-type tyrosine kinase is an oncoprotein found in 4 to 5% of non–…

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

…, K Oshima, H Morita, M Hattori, K Honda, Y Ishikawa… - Nature, 2013 - nature.com
… Il-1β −/− mice (C57BL/6) were provided by Y. Iwakura 31 . Male mice were used for all
the experiments in this study. … Hiroaki Kanda & Yuichi Ishikawa … Yuichi Ishikawa

RET, ROS1 and ALK fusions in lung cancer

…, S Okumura, K Nakagawa, H Mano, Y Ishikawa - Nature medicine, 2012 - nature.com
Through an integrated molecular- and histopathology-based screening system, we performed
a screening for fusions of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1, …

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

…, Y Satoh, S Okumura, K Nakagawa, Y Ishikawa… - Clinical Cancer …, 2009 - AACR
Purpose: EML4-ALK is a transforming fusion tyrosine kinase, several isoforms of which have
been identified in lung cancer. Immunohistochemical detection of EML4-ALK has proved …

Atomic origins of the high catalytic activity of nanoporous gold

…, S Arai, Y Yamamoto, N Tanaka, Y Ishikawa… - Nature materials, 2012 - nature.com
… Predefined directions (x and y) were chosen to be parallel and perpendicular to the surface
plane, respectively. b,c, Strain maps of ɛ x x (b) and ɛ y y (c) with a spatial resolution of 0.6 …